Azzad Asset Management Inc /Adv Abiomed Inc Transaction History

Azzad Asset Management Inc /Adv

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 01, 2024	SELL	$0.0 - $381.3 $0 - $2.8 Million	-7,331 Closed	0 $0
Q2 2022 Apr 01, 2024	BUY	$224.73 - $338.64 $194,616 - $293,262	866 Added 13.4%	7,331 $1.81 Billion
Q1 2022 Apr 01, 2024	BUY	$277.25 - $366.29 $7,485 - $9,889	27 Added 0.42%	6,465 $2.14 Billion
Q4 2021 Apr 01, 2024	BUY	$300.63 - $371.35 $300 - $371	1 Added 0.02%	6,438 $2.31 Billion
Q2 2021 Apr 01, 2024	BUY	$262.71 - $351.17 $100,092 - $133,795	381 Added 6.29%	6,437 $2.01 Billion
Q4 2020 Apr 01, 2024	BUY	$251.88 - $324.2 $609,297 - $784,239	2,419 Added 66.51%	6,056 $1.96 Billion
Q3 2020 Apr 01, 2024	BUY	$255.22 - $317.0 $928,235 - $1.15 Million	3,637 New	3,637 $1.01 Billion
Q3 2012 Apr 08, 2024	SELL	N/A	-11,000 Closed	0 $0
Q3 2011 Apr 08, 2024	BUY	N/A	11,000	11,000 $121 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.